LT3452053T - Apatinių šlapimo takų urotelinio vėžio gydymo būdas - Google Patents
Apatinių šlapimo takų urotelinio vėžio gydymo būdasInfo
- Publication number
- LT3452053T LT3452053T LTEPPCT/US2017/031445T LTUS2017031445T LT3452053T LT 3452053 T LT3452053 T LT 3452053T LT US2017031445 T LTUS2017031445 T LT US2017031445T LT 3452053 T LT3452053 T LT 3452053T
- Authority
- LT
- Lithuania
- Prior art keywords
- urothelial cancer
- treating lower
- lower tract
- tract urothelial
- treating
- Prior art date
Links
- 206010044412 transitional cell carcinoma Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Epoxy Compounds (AREA)
- Saccharide Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662333151P | 2016-05-06 | 2016-05-06 | |
| US201762443614P | 2017-01-06 | 2017-01-06 | |
| PCT/US2017/031445 WO2017193098A1 (en) | 2016-05-06 | 2017-05-05 | Method of treating lower tract urothelial cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3452053T true LT3452053T (lt) | 2023-02-10 |
Family
ID=60203435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/US2017/031445T LT3452053T (lt) | 2016-05-06 | 2017-05-05 | Apatinių šlapimo takų urotelinio vėžio gydymo būdas |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20190388338A1 (lt) |
| EP (2) | EP3452053B1 (lt) |
| JP (3) | JP7712055B2 (lt) |
| KR (2) | KR102435709B1 (lt) |
| CN (2) | CN118453872A (lt) |
| AU (1) | AU2017261371B2 (lt) |
| CA (1) | CA3023274A1 (lt) |
| ES (1) | ES2940227T3 (lt) |
| FI (1) | FI3452053T3 (lt) |
| HR (1) | HRP20221544T1 (lt) |
| HU (1) | HUE060965T2 (lt) |
| IL (2) | IL295592A (lt) |
| LT (1) | LT3452053T (lt) |
| MX (2) | MX389296B (lt) |
| NZ (3) | NZ787786A (lt) |
| PL (1) | PL3452053T3 (lt) |
| PT (1) | PT3452053T (lt) |
| RS (1) | RS64032B1 (lt) |
| RU (2) | RU2022100624A (lt) |
| SG (2) | SG11201809838VA (lt) |
| SI (1) | SI3452053T1 (lt) |
| SM (1) | SMT202300047T1 (lt) |
| WO (1) | WO2017193098A1 (lt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019500893A (ja) | 2015-11-03 | 2019-01-17 | ヤンセン バイオテツク，インコーポレーテツド | Ｐｄ−１及びｔｉｍ−３に特異的に結合する抗体及びそれらの使用 |
| KR20230133934A (ko) | 2016-10-11 | 2023-09-19 | 아게누스 인코포레이티드 | 항-lag-3 항체 및 이의 사용 방법 |
| CA3071014A1 (en) * | 2017-07-25 | 2019-01-31 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| US10792297B2 (en) | 2017-11-08 | 2020-10-06 | Taris Biomedical Llc | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine |
| US12398209B2 (en) | 2018-01-22 | 2025-08-26 | Janssen Biotech, Inc. | Methods of treating cancers with antagonistic anti-PD-1 antibodies |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY30915A1 (es) * | 2007-02-16 | 2008-09-02 | Smithkline Beecham Corp | Método de tratamiento de canceres |
| CA2765630C (en) | 2009-06-26 | 2016-07-05 | Taris Biomedical, Inc. | Solid drug tablets for implantable drug delivery devices |
| DK2512581T3 (da) | 2009-12-17 | 2021-03-29 | Taris Biomedical Llc | Implanterbar indretning med intravesikal tolerance |
| ES2639038T3 (es) * | 2010-06-02 | 2017-10-25 | Abraxis Bioscience, Llc | Métodos para el tratamiento de cáncer de vejiga |
| DK2600800T3 (da) | 2010-08-05 | 2020-11-16 | Taris Biomedical Llc | Indretning til lægemiddellevering i en ureterstent og kit dertil |
| RU2598057C2 (ru) | 2011-02-04 | 2016-09-20 | ТАРИС Биомедикал ЛЛК | Имплантируемое устройство для контролируемого высвобождения лекарственного средства с низкой растворимостью |
| JP6639228B2 (ja) * | 2012-03-29 | 2020-02-05 | アルター・バイオサイエンス・コーポレーション | 新生物を治療するための方法 |
| CN104812395A (zh) | 2012-08-31 | 2015-07-29 | 塔里斯生物医药公司 | 用于治疗前列腺的药物递送系统和方法 |
| MX365688B (es) * | 2012-08-31 | 2019-06-11 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento del cancer de vejiga que comprenden oxaliplatino. |
| JP2016508842A (ja) | 2013-03-05 | 2016-03-24 | タリス バイオメディカル エルエルシー | 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法 |
| AU2014227914B2 (en) | 2013-03-15 | 2018-05-10 | Taris Biomedical Llc | Drug delivery devices and methods for drug delivery |
| NZ711546A (en) | 2013-03-15 | 2017-12-22 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| SMT202000472T1 (it) | 2013-08-19 | 2020-11-10 | Taris Biomedical Llc | Dispositivi di somministrazione di farmaco multi-unità |
| JP6901858B2 (ja) * | 2014-03-06 | 2021-07-14 | タリス バイオメディカル エルエルシー | 薬物送達システム及びゲムシタビンによる膀胱がんの治療方法 |
| EP3160442B1 (en) | 2014-06-26 | 2019-03-06 | TARIS Biomedical LLC | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems |
| JP7425534B2 (ja) | 2015-04-23 | 2024-01-31 | タリス バイオメディカル エルエルシー | 薬物透過性構成要素を有する薬物送達デバイス及び方法 |
-
2017
- 2017-05-05 HU HUE17793523A patent/HUE060965T2/hu unknown
- 2017-05-05 IL IL295592A patent/IL295592A/en unknown
- 2017-05-05 JP JP2018558199A patent/JP7712055B2/ja active Active
- 2017-05-05 EP EP17793523.6A patent/EP3452053B1/en active Active
- 2017-05-05 IL IL262746A patent/IL262746B/en unknown
- 2017-05-05 FI FIEP17793523.6T patent/FI3452053T3/fi active
- 2017-05-05 NZ NZ787786A patent/NZ787786A/en unknown
- 2017-05-05 US US16/099,179 patent/US20190388338A1/en active Pending
- 2017-05-05 NZ NZ748252A patent/NZ748252A/en unknown
- 2017-05-05 AU AU2017261371A patent/AU2017261371B2/en active Active
- 2017-05-05 KR KR1020187035297A patent/KR102435709B1/ko active Active
- 2017-05-05 PL PL17793523.6T patent/PL3452053T3/pl unknown
- 2017-05-05 SM SM20230047T patent/SMT202300047T1/it unknown
- 2017-05-05 LT LTEPPCT/US2017/031445T patent/LT3452053T/lt unknown
- 2017-05-05 HR HRP20221544TT patent/HRP20221544T1/hr unknown
- 2017-05-05 PT PT177935236T patent/PT3452053T/pt unknown
- 2017-05-05 CN CN202410626384.1A patent/CN118453872A/zh active Pending
- 2017-05-05 RU RU2022100624A patent/RU2022100624A/ru unknown
- 2017-05-05 ES ES17793523T patent/ES2940227T3/es active Active
- 2017-05-05 EP EP22212024.8A patent/EP4209221A1/en active Pending
- 2017-05-05 RS RS20230163A patent/RS64032B1/sr unknown
- 2017-05-05 SG SG11201809838VA patent/SG11201809838VA/en unknown
- 2017-05-05 WO PCT/US2017/031445 patent/WO2017193098A1/en not_active Ceased
- 2017-05-05 SI SI201731301T patent/SI3452053T1/sl unknown
- 2017-05-05 RU RU2018142908A patent/RU2764747C2/ru active
- 2017-05-05 SG SG10201913416PA patent/SG10201913416PA/en unknown
- 2017-05-05 CA CA3023274A patent/CA3023274A1/en active Pending
- 2017-05-05 KR KR1020227028547A patent/KR20220123317A/ko not_active Ceased
- 2017-05-05 MX MX2018013432A patent/MX389296B/es unknown
- 2017-05-05 NZ NZ787824A patent/NZ787824A/en unknown
- 2017-05-05 CN CN201780040391.1A patent/CN109475571A/zh active Pending
-
2018
- 2018-11-01 MX MX2021013461A patent/MX2021013461A/es unknown
-
2021
- 2021-10-21 JP JP2021172052A patent/JP2022009327A/ja not_active Withdrawn
-
2023
- 2023-12-07 JP JP2023206570A patent/JP2024028881A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275663A (en) | Cancer treatment methods | |
| IL263925A (en) | Methods of treating ovarian cancer | |
| ZA201804227B (en) | Methods of treating cancer | |
| IL255189A0 (en) | Cancer treatment methods | |
| IL255569A (en) | Methods of treating cancer using anti-ox40 antibodies | |
| HUE052106T2 (hu) | Eljárás rák kezelésére | |
| SG10201801562PA (en) | Combination method for treatment of cancer | |
| IL262342A (en) | Cancer treatment methods | |
| IL262005A (en) | Methods of treating cancer in children | |
| ZA201808258B (en) | Methods of treating pancreatic cancer | |
| ZA201802481B (en) | Novel biomarkers and methods of treating cancer | |
| IL262746A (en) | A method for treating urothelial cancer in the lower system | |
| ZA201908539B (en) | Method of treatment of cancer | |
| IL263835A (en) | Exosome-guided treatment of cancer | |
| GB201717945D0 (en) | Method for treatment of cancer | |
| SG11202005163PA (en) | Methods of treating cancer | |
| IL269123A (en) | Methods of treating cancer | |
| GB201510197D0 (en) | Method of treating ovarian cancer | |
| GB201622214D0 (en) | treatment of cancer | |
| GB201604621D0 (en) | Treatment of cancer | |
| GB201604293D0 (en) | Treatment of cancer |